(Q33160437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

James Baggs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Martin Kulldorff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10

Matthew F Daley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

Eric S Weintraub

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1

Julianne Gee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

11

Nicola P Klein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

9

Bruce Fireman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Irene Shui

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ruihua Yin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Rong Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Edwin Lewis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

9 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

8279-8284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21907257%20AND%20SRC:MED&resulttype=core&format=json

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Real-time vaccine safety surveillance for the early detection of adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Risk of Anaphylaxis After Vaccination of Children and Adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Influenza vaccination and mortality: differentiating vaccine effects from bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Safety of human papillomavirus (HPV) vaccines: a review of the international experience so far.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106

Anaphylaxis following quadrivalent human papillomavirus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.106